Elan Drug Technologies

Elan Drug Technologies has developed a range and depth of solid oral dosage technologies unrivalled in the drug delivery industry. Elan Drug Technologies has been applying its' range of technology approaches to help overcome many of the technical difficulties that have been encountered by pharmaceutical companies.


Some of Elan Drug Technologies’ patented oral delivery technologies are described below, including:

SODAS® Technology
Multiparticulate delivery system, providing tailored, highly flexible release profiles including controlled release, immediate release and pulsatile release of drug

IPDAS® Technology

Controlled release tablet technology, designed for use with more gastrointestinal irritant compounds.

CODAS® Technology
Technology for tailored release of drug to allow chronotherapeutic delivery.

PRODAS™ Technology

Multiparticulate minitab technology system, that combines the benefits of tabletting technology within a capsule. 

MXDAS® Technology

Hydrophilic matrix technology which controls the release of drug through a process of diffusion and erosion in the gastrointestinal tract.  

DUREDAS® Technology

Bilayer tablet which can provide immediate or sustained release of two drugs or different release rates of the same drug in one dosage form.

If you would like to discuss these or other of Elan Drug Technologies’ customised and patented technology approaches, please contact us.